Eneboparatide
N/A
Report date: 2025/04/28 22:35:30
Base Information
Drug NameEneboparatide
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[14]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHarvard Medical SchoolMassachusetts General Hospital
China Registration ClassN/A
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive Indications